| 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | -1,1 k € | +67.7% | -3,5 k € | +46.0% | -6,6 k € | -82.7% | -3,6 k € | |
| EBITDA | -1,1 k € | +67.7% | -3,5 k € | +46.0% | -6,6 k € | -82.7% | -3,6 k € | |
| Operating profit | -1,1 k € | +67.7% | -3,5 k € | +46.0% | -6,6 k € | -82.7% | -3,6 k € | |
| Profit/loss | -606,0 € | +81.8% | -3,3 k € | +50.0% | -6,7 k € | -83.0% | -3,6 k € | |
| Equity | 63,6 k € | -0.9% | 64,3 k € | -4.9% | 67,6 k € | -9.0% | 74,2 k € | |
| Total assets | 78,9 k € | -0.8% | 79,5 k € | -4.0% | 82,8 k € | -7.4% | 89,5 k € | |
| Cash | 78,9 k € | -0.8% | 79,5 k € | -4.0% | 82,8 k € | -7.4% | 89,5 k € | |
Private foundation · Auderghem · incorporated on 30/05/2007
Private foundation loss-making in the latest fiscal year.
Solid counterparty for a standard engagement.
Belgian hadron therapy consortium is a Private foundation incorporated in 2007. Its registered office is in Auderghem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette